期刊文献+

原发性肾上腺淋巴瘤7例临床分析

Clinical analysis of 7 cases of primary adrenal lymphoma
下载PDF
导出
摘要 目的探讨原发性肾上腺淋巴瘤(PAL)患者的临床特征、治疗情况及预后。方法回顾性分析7例PAL患者,包括弥漫大B细胞淋巴瘤(DLBCL)6例、NK/T细胞淋巴瘤1例的临床资料。结果7例患者中位年龄为63(39~76)岁,男6例,女1例;双侧发病5例,单侧发病2例;7例患者均接受单侧肾上腺肿块切除术。DLBCL组5例化疗,2例(40%)完全缓解(CR),1例(20%)部分缓解(PR),总反应率(0 RR)为60%;NK/T细胞淋巴瘤患者采用以左旋门冬酰胺酶为主的方案化疗联合放疗,患者达CR。4例DLBCL患者分别生存0.2、2.7、2.8、9.6个月后死亡。结论PAL很罕见,恶性度高,预后差,DLBCL最常见,好发于老年男性,双侧多见,治疗上以联合化疗为主。 Objective To explore the clinical characteristics,treatment and prognosis of patients with primary adrenal lymphoma(PAL).Methods The clinical data of 7 cases of PAL were retrospectively analyzed,including 6 cases of diffuse large B-cell lymphoma(DLBCL)and 1 case of NK/T-cell lymphoma.Results The median age of 7 patients was 63 years(range 39-76 years),6 cases were male and 1 case was female.Two cases presented with unilateral and 5 cases with bilateral masses.All the 7 patients underwent unilateral adrenalectomy.Of the 6 cases with DLBCL,5 cases received chemotherapy,of which complete remission(CR)was achieved in 2 cases(2/5)and partial remission(P R)was achieved in 1 case(1/5),and the overall response rate(ORR)was 60%(3/5).The 1 case with NK/T cell lymphoma was treated with L-asparaginase based chemotherapy combined with radiotherapy,and the patient achieved CR.Four cases of DLBCL died with a follow-up survival time of 0.2,2.7,2.8,and 9.6 months,respectively.Conclusions PAL is rare with high malignancy and poor prognosis.DLBCL is the most common type of PAL,predominantly occurring in elderly males and mostly bilateral presence.Combined chemotherapy is the main treatment for PAL.
作者 杨晶晶 桑威 闫冬梅 宋旭光 田宇 李庆 周航 徐开林 YANG Jingjing;SANG Wei;YAN Dongmei;SONG Xuguang;TIAN Yu;LI Qing;ZHOU Hang;XU Kailin(Department of Hematology,the Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu 221002,China;Department of Pathology,the Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu 221002,China)
出处 《徐州医科大学学报》 CAS 2019年第11期847-850,共4页 Journal of Xuzhou Medical University
基金 “科教强卫工程”青年医学人才(QNRC2016791) 江苏省自然科学基金(BK20171181)
关键词 肾上腺肿瘤 淋巴瘤 诊断 预后 adrenal neoplasms lymphoma diagnosis prognosis
  • 相关文献

参考文献2

二级参考文献34

  • 1寿建忠,马建辉,肖振东,毕新刚,李长岭.肾上腺淋巴瘤的临床与病理特点分析[J].中华泌尿外科杂志,2007,28(4):221-223. 被引量:13
  • 2Korl AD, le Gessie S, Snijder S, et al. Primary extranodal non- Hodgkin' s lymphoma (NHL): the impact of alternative defini- tions tested in the Comprehensive Cancer Centre West popula- tion-based NHL registry. Ann Oncol, 2003, 14:131-139.
  • 3Li XQ, Li GD, Gao ZF, et al. The relative frequencies of lympho- ma subtypes in China: a nationwide study of 10002 cases by the Chinese Lymphoma Study Group. Ann Oncol, 2011, 22 Suppl 4: ivl41.
  • 4Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a stan- dard regimen (CHOP) with three intensive chemotherapy regi- mens for advanced non-Hodgkin' s lymphoma. N Engl J Med, 1993, 328:1002-1006.
  • 5Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med, 2005, 352:1197-1205.
  • 6Coiffier B, Thieblemont C, Van Den Neste E,et ah Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemother- apy in DLBCL patients: a study by the Grouped' Etudes des Lymphomes de 1' Adulte. Blood, 2010, 116:2040-2045.
  • 7Seki R, Ohshima K, Nagafuji K, et al. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group. Int J Hematol, 2010, 9 I: 258-266.
  • 8Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol, 2005, 23:5027-5033.
  • 9Habermama TM, Weller EA, Morrison VA, et al. Rituximab- CHOP versus CHOP alone or with maintenance rituximab in old- er patients with diffuse large B-cell lymphoma. J Clin Oncol, 2006, 24:3121-3127.
  • 10Tilly H, Dreyling M. ESMO Guidelines Working Group. Diffuse large B-cell non-Hodgkin' s lymphoma: ESMO clinical recom- mendations for diagnosis, treatment and follow-up. Ann Oncol, 2008, Suppl 2:ii67-69.

共引文献258

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部